1 / 11

SMALL MOLECULE CANCER DRUGS MARKET

Cancer is a chronic condition that involves abnormal growth of cell. Interference due to genetic changes causes uncontrollable growth of cells and results into formation of a mass called tumor. The tumor is malignant type, it is capable to spread all over the body. Most of the cancer occur due to genetic mutation, induced due to environmental factors or lifestyle, or it can be hereditary also. It is classified into four categories on the basis of its origin u2013 1) Carcinoma (begins in skin or tissue) 2) Sarcoma (begins in connective tissues) 3) Lymphoma (begins in lymphatic system) 4) Leukemia (begins in blood).

PrashilCMI
Download Presentation

SMALL MOLECULE CANCER DRUGS MARKET

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. SMALL MOLECULE CANCER DRUGS MARKET Cancer is a chronic condition that involves abnormal growth of cell. Interference due to genetic changes causes uncontrollable growth of cells and results into formation of a mass called tumor. The tumor is malignant type, it is capable to spread all over the body. Most of the cancer occur due to genetic mutation, induced due to environmental factors or lifestyle, or it can be hereditary also. It is classified into four categories on the basis of its origin – 1) Carcinoma (begins in skin or tissue) 2) Sarcoma (begins in connective tissues) 3) Lymphoma (begins in lymphatic system) 4) Leukemia (begins in blood).

  3. Global Small Molecule Cancer Drugs Market Drivers Approvals for small molecule cancer drugs by regulatory bodies to key players are expected to boost the global small molecule cancer drugs market growth. For instance, in May 2019, U.S. Food & Drug Administration (FDA) approved a drug, Piqray in combination with fluvestrant, which is manufactured by Novartis AG. It is the first ever drug that is specifically being used for the treatment of HR/HER2-, PIK3CA mutated advanced breast cancer. Similarly, in April 2019, Janssen Pharmaceutical Company received U.S. FDA approval for Balversa (erdafitinib). It is indicated for the treatment of FGFR3 or FGFR2 mutated, locally advanced urothelial carcinoma. The type of study was multicenter, open-label, single-arm trial and comprised 87 participants diagnosed with locally advanced or metastatic urothelial carcinoma and had progressed on or after at least one prior chemotherapy. Furthermore, key players are also focused on growth strategies such as collaborations, mergers and acquisitions to gain competitive edge in the market. For instance, in June 2019, Pfizer Inc., a pharmaceutical company acquired Array Biopharma, a drug developer company for expansion of its product portfolio.

  4. Global Small Molecule Cancer Drugs Market Regional Analysis North America is expected to hold a dominant position in global small molecule cancer drugs market, owing to initiatives taken by other organizations related to cancer drugs. For instance, in June 2019, American Cancer Society partnered with Ovarian Cancer Research Alliance to fund research activities related to detection, treatment and prevention of ovarian cancer. Its goal is to raise funds for research activities, so as to support them for investigation of drugs for ovarian cancer. Hence, such initiatives may have a positive influence on the global small molecule cancer drugs market growth.

  5. Global Small Molecule Cancer Drugs Market Restraints Side-effects of drugs is expected to hamper the global small molecule cancer drugs market growth. The side-effects depend mainly upon the type of cancer and the overall health of the patient. It can cause muscle pain, headache, fatigue, mouth sores, nausea, vomiting, throat sores, diarrhea, and constipation. As these drugs effect healthy cells, in turn, affecting the process of regenerating new blood cells. Hence, this factor may obstruct the global small molecule cancer drugs market growth. Global Small Molecule Cancer Drugs Market Key Players Some of the major players operating in the small molecule cancer drugs market include, Otsuka Pharmaceutical Co. Ltd, Eli Lilly and Co, Janssen Research and Development LLC, Novartis AG, Pfizer Inc., SANOFI AVENTIS US LLC, Baxter Healthcare Corp., Emcure Pharmaceuticals Ltd., AstraZeneca, Kyowa Kirin Inc., and HQ Specialty Pharma Corp

  6. Global Small Molecule Cancer Drugs Market Taxonomy The global small molecule cancer drugs market is segmented on the basis of drug class, route of administration, distribution channel, and regions.  • By Drug Class • Alkylating Agents • Plant Alkaloids • Antitumor Antibiotics • Antimetabolites • Topoisomerase Inhibitors • Others • By Route of Administration • Oral • Injectable

  7. By Distribution Channel • Hospital pharmacies • Retail pharmacies • Online pharmacies • By Region • North America • Latin America • Europe • Asia Pacific • Middle East • Africa

  8. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. •  What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  9. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • CMI Services • CMI Latest Insights • CMI Blogs

  10. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  11. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related